| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO And Chief Corp. Deve. Off.
1 company
Sander Dale A. is a CFO And Chief Corp. Deve. Off. at Humacyte, Inc.. Recent SEC Form 4 filings include 3 buys and 1 sell.
Estimated insider holdings value: $354K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2025 | HUMA Humacyte, Inc. | CFO And Chief Corp. Deve. Off. | Buy | 20,000 | $1.53 | $30,600.00 | +97.1% | +61.8% | -58.9% | |
| Aug 27, 2024 | HUMA Humacyte, Inc. | CFO And Chief Corp. Deve. Off. | Sale+OE | 39,389 | $6.68 | $263,118.52 | -95.2% | -35.7% | -77.0% | |
| Dec 16, 2022 | HUMA Humacyte, Inc. | CFO And Chief Corp. Deve. Off. | Buy | 20,000 | $2.60 | $52,000.00 | +3,333% | +14.1% | +24.1% | |
| May 17, 2022 | HUMA Humacyte, Inc. | CFO And Chief Corp. Deve. Off. | Buy | 2,000 | $4.53 | $9,060.00 | New | +1.1% | -12.5% |